Rodilla, Panny C.
HRN: 22-57-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2023
AMPICILLIN 1GM (VIAL)
02/03/2023
02/09/2023
IVT
2gms
Q6
G1p0 Pu 40 1/7 Weeks Aog By Lmp, Prom X14hrs
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes